Physician

Alfonso Ciervo, MD

According to 2025 Medicare claims, Alfonso Ciervo, MD (NPI: 1457346918) practices vascular surgery in the Lakewood-New Brunswick, NJ market, with the plurality of this provider's patient population coming from Monmouth, NJ. This provider's primary affiliated billing organization is INNOVATIVE VASCULAR GROUP (NPI: 1477591006; TIN: 900194764) and primary practice location at 07733-1514.

Ciervo's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 823 traditional Medicare patients, billed 2,334 HCPCS/CPT codes, and received $281,628 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 558 prescription claims across 188 beneficiaries totaling $221,828 in drug costs, led by Eliquis (Apixaban). DME data shows 11 claims. Open Payments data shows 4 records totaling $184. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved from a higher plateau to a lower plateau, from $651,502 to $281,628. In contrast, Part D prescription costs have moved sharply higher in recent years, from $10,624 to $221,828. For DME billing, this smaller-volume category moved up and down with repeated peaks and valleys, starting at $8,454 and ending at $4,457.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	683	2,390	$651,502
2016	898	2,989	$762,789
2017	930	3,456	$925,539
2018	974	9,605	$694,659
2019	840	2,703	$408,667
2020	868	2,789	$398,760
2021	850	2,865	$402,185
2022	801	2,612	$363,291
2023	788	2,465	$328,330
2024	823	2,334	$281,628

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	118	230	$10,624
2016	114	238	$24,978
2017	126	288	$34,619
2018	130	340	$49,233
2019	143	392	$52,673
2020	155	473	$115,142
2021	149	412	$154,571
2022	166	451	$151,222
2023	204	613	$230,510
2024	188	558	$221,828

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	23	$1,073
2023	N/R	11	$1,169
2024	N/R	11	$1,258

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	122	137	$99
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	222	231	$91
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	124	125	$84
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	205	319	$71
76937	Ultrasonic guidance for blood vessel access	148	173	$11

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Eliquis	Apixaban	172	9,191	$171,991
Xarelto	Rivaroxaban	28	2,091	$37,311
Clopidogrel	Clopidogrel Bisulfate	109	9,770	$1,124
Cilostazol	Cilostazol	21	1,212	$786
Cephalexin	Cephalexin	58	361	$431

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4416	Ostomy pouch, closed, with barrier attached, with filter (1 piece), each	N	N/R	11	$1,258

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	4	$184	W. L. Gore & Associates, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Alfonso Ciervo, MD?

Tedicare shows public-source Medicare data for Alfonso Ciervo, MD (NPI 1457346918), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alfonso Ciervo, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alfonso Ciervo, MD?

Alfonso Ciervo, MD is linked to INNOVATIVE VASCULAR GROUP (billing NPI 1477591006) in the available physician profile data.

Does Alfonso Ciervo, MD have Open Payments data?

Alfonso Ciervo, MD has 4 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.